Spirepoint Private Client’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$597K Sell
6,574
-1,927
-23% -$176K 0.05% 180
2026
Q1
$873K Sell
8,501
-1,863
-18% -$210K 0.08% 133
2025
Q4
$1.3M Buy
10,364
+95
+0.9% +$12.1K 0.12% 101
2025
Q3
$1.38M Buy
10,269
+34
+0.3% +$4.46K 0.14% 99
2025
Q2
$1.39M Sell
10,235
-83
-0.8% -$10.9K 0.16% 89
2025
Q1
$1.37M Sell
10,318
-213
-2% -$27.1K 0.18% 75
2024
Q4
$1.19M Buy
10,531
+2,545
+32% +$294K 0.15% 89
2024
Q3
$910K Sell
7,986
-177
-2% -$19.4K 0.12% 106
2024
Q2
$848K Sell
8,163
-183
-2% -$19.4K 0.12% 106
2024
Q1
$949K Buy
+8,346
New +$957K 0.14% 95

Other funds holding ABT

Spirepoint Private Client's ABT Position: Q2 2026 in Review

Spirepoint Private Client reduced its Abbott (ABT) stake by 23% in Q2 2026, selling an estimated $176K and leaving 6,574 shares worth $597K. The position accounts for 0.05% of the portfolio, ranked #180.

Spirepoint Private Client first reported a position in ABT in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.39M in Q2 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Spirepoint Private Client held 6,574 shares of Abbott worth $597K as of Q2 2026.
  • Spirepoint Private Client sold 1,927 Abbott shares in Q2 2026, an estimated $176K.
  • Abbott made up 0.05% of Spirepoint Private Client's portfolio in Q2 2026, its #180 holding.
  • Spirepoint Private Client first reported a position in Abbott in Q1 2024 and has held it in 10 quarters since.
  • Spirepoint Private Client's Abbott position peaked at $1.39M in Q2 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.